Top Stock Movers Oct 5, 2026: MI, VEEA, BEAT

MI — NFT Ltd (+666.2%)

NFT Ltd (MI) closed at $6.85, up an extraordinary +666.2% on the day, making it the single biggest gainer in the US market on October 5. Volume was stunning: 353,080,611 shares traded, versus a 20-day average of just 17,739,774 — more than 19× normal. The stock also gapped up at the open by +233.9%, meaning much of the move was locked in before most traders could react.

No direct catalyst for MI could be confirmed from the available headlines or SEC filings. The recent filings are routine 6-Ks (foreign-issuer event reports) and a Schedule 13G/A amendment (a passive-stake disclosure) — none of which typically drive moves of this magnitude. The catalyst here is unclear, and the move appears to be momentum- and technically-driven. MI has a market cap of just $3.0 million, which makes it one of the smallest-cap names in the US market. At that size, even a modest dollar inflow can produce violent price swings.

The short-squeeze angle is limited: short interest is only 36,889 shares with 0.1 days to cover (days to cover = short interest ÷ average daily volume, measuring how long it would take shorts to buy back shares — a low number means shorts can exit quickly and aren't trapped). The squeeze score sits at just 6/100. This is not a squeeze story; it is a micro-cap momentum event. The RSI (Relative Strength Index, a 0–100 momentum gauge where readings above 70 signal overbought territory) printed 72, and the ADX (Average Directional Index, measuring trend strength) hit 40 — confirming a strong trend in motion, even if short-lived. The stock is still -98.8% below its 52-week high, underscoring how far it fell before today. Conviction score is 38/100 (grade D).

Moves like this in sub-$5M market-cap stocks are extraordinarily high risk. Thin stocks can collapse as fast as they rise. MI also featured in today's premarket recap — see Premarket Movers Oct 5, 2026 for earlier context.

VEEA — VEEA INC. (+72.7%)

VEEA Inc., a technology company, closed at $5.75, up +72.7% on volume of 39,095,738 shares — roughly 2× its 20-day average of 19,561,665. The stock opened with a gap of +59.9%, so the bulk of the gain was established at the bell.

The most recent notable development for VEEA was reported on October 2: the company raised $1.65 million in unsecured demand notes from NLabs at 10% interest for working capital, per TipRanks, TradingView, and Stock Titan. A CEO affiliate provided the loans across four tranches, and VEEA filed an 8-K (a material-event disclosure companies are required to file with the SEC) confirming the agreement. While insider-backed emergency working capital loans can sometimes signal financial stress, markets appear to have read this as a confidence signal from insiders willing to put their own capital into the business. VEEA had also appeared in recent recaps — After-Hours Movers Oct 2, 2026 and Top Stock Movers Oct 1, 2026 — suggesting the stock has been in active play for several sessions.

Technically, VEEA earned a conviction score of 69/100 (grade B) — the strongest in today's lineup — and an RS (Relative Strength) rating of 85, meaning it outperformed 85% of all US stocks over the relevant lookback period. RSI closed at 68 (approaching but not yet in overbought territory) and ADX at 41 (strong trend). The free float is a relatively tight 43.5% (meaning only 43.5% of shares are available for public trading — a low float amplifies price moves). Short interest is 671,095 shares with 2.8 days to cover and a squeeze score of 20/100 — some short pressure, but not a primary driver. The stock remains -61.1% below its 52-week high, so there is significant overhead resistance. Trend-template score is 3/5.

BEAT — HeartBeam, Inc. (+54.0%)

HeartBeam, Inc. (BEAT) surged +54.0% to close at $0.67 on volume of 156,264,569 shares — nearly 19× its 20-day average of 8,288,978. The stock gapped up +72.3% at the open before trimming gains slightly into the close.

The catalyst is clear and significant: HeartBeam received FDA Breakthrough Device Designation for its heart attack assessment technology, according to Yahoo Finance and Stock Titan on October 5. The FDA's Breakthrough Device program is designed to speed the development and review of medical devices that provide more effective treatment or diagnosis of serious conditions. For a small-cap medical device company, this designation is a meaningful de-risking event — it typically signals the FDA is willing to work collaboratively and prioritize review, which can shorten the path to commercialization. BEAT was also highlighted in Premarket Movers Oct 5, 2026, where it was already active ahead of the open.

The technical picture reflects the news jolt: RSI hit 77 (overbought), meaning the stock is stretched in the short term. The gap is +72.3% — a gap up (when a stock opens meaningfully above its prior close) of this size often leads to volatile intraday action, which the volume data confirms. The free float is 75.0% with short interest of 1,941,356 shares and 6.4 days to cover — the highest days-to-cover in today's group — and a squeeze score of 41/100. With shorts needing 6+ days to exit at average volume, a continued run could force short covering, adding fuel. That said, conviction sits at 49/100 (grade C) and the stock is still -80.5% below its 52-week high, highlighting how depressed it was before today. ADX of 22 suggests the trend was not yet established coming in.

Reddit activity also picked up, with BEAT ranking #31 on r/all-stocks with 14 mentions — retail attention was building.

QTEX — QTREX Quantum Ltd. (+42.7%)

QTREX Quantum Ltd. (QTEX) closed up +42.7% to $1.57 on 66,201,420 shares, versus a 20-day average of 11,887,700 — about 5.6× normal activity. The stock opened with a gap of +18.6%.

The catalyst traces back to a headline from The Globe and Mail on October 2: "QTREX Quantum Reports Breakthrough Cryogenic Interconnect Test, Moves to Finalize Major Quantum Agreement." That suggests the company announced a technical milestone in its quantum computing hardware and is working toward a significant commercial deal. Benzinga also covered the stock on October 2 ("QTREX Quantum Stock Climbs Friday: What's Going On?"), and Timothy Sykes noted it extending its intraday surge on October 3. The momentum appears to have carried into today's session.

QTEX is categorized in Healthcare but the quantum computing angle fits the tech/hardware space. Market cap is $39.7M, free float is 83.3%, and short interest is 3,835,792 shares with only 0.9 days to cover — so a short squeeze isn't the primary story despite a squeeze score of 52/100. However, short-volume was 57% on the day, meaning more than half of today's volume was executed on the short side — suggesting active short-sellers are engaging the move, which creates the potential for volatility in both directions. RSI at 79 is in overbought territory. The technical rank of 100 (the highest in today's group) is notable. Smart-money score is 36/100, and CEO Ben-Noon Dagi Shahar bought 168,894 shares (~$120K) on September 28 — a fresh insider purchase ahead of the move, which StockSetups flags as a positive smart-money signal.

APUS — Apimeds Pharmaceuticals US, Inc. (+36.3%)

Apimeds Pharmaceuticals US, Inc. (APUS) closed up +36.3% to $4.39 on 21,010,688 shares — about 2.8× its 20-day average of 7,536,389. The stock gapped up +53.7% at the open and then whipsawed through the session, closing well below intraday highs.

The catalyst is not clearly defined by the available data. Multiple outlets — Benzinga, Timothy Sykes, and StocksToTrade — covered APUS on October 5, but the framing is about trader behavior and volatility ("Whipsaws After Huge Run," "Traders Target Extreme Volatility," "Zero In On Volatility And Cash Burn") rather than a fundamental news event. Recent 8-K filings (October 1, September 29, September 23, September 11) cover management changes, bylaw amendments, and an agreement — none of which individually explain a +36% surge. The catalyst is unclear, and the move appears momentum-driven, fueled by traders chasing prior-day volatility. APUS has appeared in StockSetups recaps before — see Top Stock Movers Sept 24, 2026 and Premarket Movers Sept 24, 2026.

The stock's profile makes it high-risk: market cap is just $4.8M, RSI is 53 (neutral, meaning the momentum is not as stretched as peers in today's list), and the squeeze score is only 8/100 with just 0.1 days to cover — no real short squeeze dynamic. Short-volume was 51%, consistent with active two-sided trading. Free float is 54.4%. Conviction is 38/100 (grade D). The stock sits -87.5% below its 52-week high, so prior buyers are deeply underwater. The "cash burn" language in the press coverage is a red flag worth noting: small pharma companies with cash concerns face dilution risk, which can pressure shares sharply.

The bottom line

Today's biggest gainers — MI (+666%), VEEA (+73%), BEAT (+54%), QTEX (+43%), and APUS (+36%) — illustrate the full spectrum of what drives explosive single-session moves: a confirmed FDA catalyst (BEAT), an insider-backed capital raise (VEEA), a quantum tech milestone (QTEX), and pure momentum in ultra-micro-caps (MI, APUS).

A few honest reminders before you act on any of this:

• Chasing extended gainers is high-risk. Stocks that gap 50–700% in a single session frequently give back a large portion of those gains in the days that follow — sometimes within hours. The RSI readings of 72–79 across most of today's names signal they are overbought in the short term.
• Low float and momentum cuts both ways. The same thin liquidity that drives a stock up 600% can drain it just as fast when sellers appear.
• Patterns and squeeze setups fail. Technical signals and short-squeeze dynamics are probabilities, not guarantees. Manage your risk accordingly.
• This is educational content, not financial advice. Do your own research before making any trading decisions.

StockSetups scans the full ~12,300-stock US universe after every close, detecting confirmed chart patterns, computing conviction and squeeze scores, and sorting long setups into actionable lanes — so you see the next day's potential movers before the open. Check back each evening for the latest after-close scan results.